CASI Pharmaceuticals Reports Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Shipping stocks on fire — but cracks are forming in the rate rally
CASI Pharma (CASI) Reports Q2 Loss of $0.06/Share
August 14, 2015 7:06 AM EDTCASI Pharma (NASDAQ: CASI) reported Q2 EPS of ($0.06), versus ($0.06) reported last year. Revenue for the quarter came in at $24 thousand, versus $0 reported last year.
For earnings history and earnings-related data on CASI Pharma (CASI) click here.
... More